| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |